Strategies for the Responsible Sharing of Clinical Trial Data: Guiding Principles and a Framework for Implementation
Strategies for the Responsible Sharing of Clinical Trial Data: Guiding Principles and a Framework for Implementation
批准号:
8839023
负责人:
Anne B Claiborne
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-12 至 2015-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Over the course of 17 months, the committee will hold five meetings as well as at least one
public workshop that involves international participants. At least two of these meetings will
allocate time for public comment to be received. The committee will also identify other avenues
for receiving input from interested stakeholders. Nominations for the study committee will be
sought from a variety of sources, including NIH, FDA, other relevant federal agencies, the IOM
and NAS membership, relevant IOM Boards and Roundtables, academic institutions,
professional associations, patient and family groups, and other expert and stakeholder groups.
Care will be taken to ensure that the committee is balanced and has the necessary research,
policy, and work experience. The work of committee members and staff may be supplemented
by consultants to provide additional expertise, for example, through the preparation of
background papers.
The first committee meeting will be a four-day meeting. It will include a critical examination of
the charge to the committee through in-depth discussion with the project sponsors about the
tasks and existing data sharing activities, as well as planning of a public workshop to be held in
conjunction with the second meeting. The committee will also create a framework for discussion
that will be subject to institutional review procedures prior to its release, which is planned for
January 2014.The framework for discussion will be released for public comment to stimulate
comments and input from the public that could inform the committee's deliberations. The second
meeting will include the conduct of a public workshop to obtain public input on the framework for
discussion and generally on issues within the scope of the committee's charge. The third and
fourth meetings will be used to develop and refine draft report findings and to organize the
writing of the report; the third meeting will also include the conduct of a second public workshop
to obtain public input to the committee on the analysis and governance of the selected data
sharing activities. The fifth meeting will be used to reach final agreement on the committee
findings, recommendations, and the preparation of the draft report for review. The report will be
subject to institutional review procedures prior to release. A prepublication copy of the report is
expected to be delivered to the sponsors after 17 months following the start of the project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION
-
批准号:9091015
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2015
-
负责人:Anne B Claiborne
-
依托单位:
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceuticals: An IOM Workshop
-
批准号:8996009
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2015
-
负责人:Anne B Claiborne
-
依托单位:
FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION
-
批准号:8838373
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2014
-
负责人:Anne B Claiborne
-
依托单位:
海外基金